Axonics Modulation Technologies

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXNX and other ETFs, options, and stocks.

About AXNX

Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. 

CEO
Raymond Wayne Cohen
CEORaymond Wayne Cohen
Employees
517
Employees517
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
2012
Founded2012
Employees
517
Employees517

AXNX Key Statistics

Market cap
3.44B
Market cap3.44B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
515.33K
Average volume515.33K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$79.92
52 Week high$79.92
52 Week low
$38.41
52 Week low$38.41

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

AXNX Earnings

-$0.63
-$0.42
-$0.21
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.